Department of Children Diseases, Medical Academy, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
Vilnius University Hospital Santaros Klinikos, LT-08406 Vilnius, Lithuania.
Medicina (Kaunas). 2021 Jan 26;57(2):112. doi: 10.3390/medicina57020112.
The data on the prevalence of chronic kidney disease (CKD) in the pediatric population are limited. The prevalence of CKD ranges from 56 to 74.7 cases per million of the age-related population (pmarp). The most common cause of CKD among children is congenital anomalies of the kidney and urinary tract (CAKUT). With progressing CKD, various complications occur, and end-stage renal disease (ESRD) can develop. The aim of the study was to determine the causes, stage, prevalence, and clinical signs of CKD and demand for RRT (renal replacement therapy) among Lithuanian children in 2017 and to compare the epidemiological data of CKD with the data of 1997 and 2006. The data of 172 Lithuanian children who had a diagnosis of CKD (stage 2-5) in 1997 ( = 41), in 2006 ( = 65), and in 2017 ( = 66) were retrospectively analyzed. Physical development and clinical signs of children who had CKD (stage 2-5) in 2017 were assessed. The prevalence of CKD stages 2-5 was 48.0 pmarp in 1997; 88.7 in 2006; and 132.1 in 2017 ( < 0.01). Congenital and hereditary diseases of the kidney in 1997 accounted for 66% of all CKD causes; in 2006, for 70%; and in 2017, for 79%. In 2017, children with CKD stages 4 or 5 (except transplanted children) had hypertension (87.5%) and anemia (50%) ( < 0.01). Children under ≤2 years with CKD were at a 3-fold greater risk of having elevated blood pressure (OR = 3.375, 95% CI: 1.186-9.904). There was no change in the number of children with CKD in Lithuania; however, the prevalence of CKD increased due to reduced pediatric population. CAKUT remains the main cause of CKD at all time periods. Among children with CKD stages 4 or 5, there were more children with hypertension and anemia. In children who were diagnosed with CKD at an early age hypertension developed at a younger age.
儿童慢性肾脏病(CKD)的流行数据有限。CKD 的流行率范围为每百万年龄相关人群(pmarp)56 至 74.7 例。儿童 CKD 的最常见原因是肾脏和泌尿道先天异常(CAKUT)。随着 CKD 的进展,会发生各种并发症,并且可能发展为终末期肾脏疾病(ESRD)。本研究的目的是确定 2017 年立陶宛儿童 CKD 的病因、分期、流行率和对肾脏替代治疗(RRT)的需求,并将 CKD 的流行病学数据与 1997 年和 2006 年的数据进行比较。对 1997 年(=41 例)、2006 年(=65 例)和 2017 年(=66 例)诊断为 CKD(第 2-5 期)的 172 名立陶宛儿童的数据进行回顾性分析。评估了 2017 年患有 CKD(第 2-5 期)的儿童的身体发育和临床体征。1997 年 CKD 第 2-5 期的流行率为 48.0 pmarp;2006 年为 88.7;2017 年为 132.1(<0.01)。1997 年,所有 CKD 病因中,先天性和遗传性肾脏疾病占 66%;2006 年占 70%;2017 年占 79%。2017 年,CKD 第 4 或 5 期(移植儿童除外)的儿童患有高血压(87.5%)和贫血(50%)(<0.01)。<2 岁的 CKD 儿童患高血压的风险增加 3 倍(OR=3.375,95%CI:1.186-9.904)。立陶宛的 CKD 儿童人数没有变化,但由于儿科人口减少,CKD 的流行率有所增加。CAKUT 始终是 CKD 的主要原因。在 CKD 第 4 或 5 期的儿童中,高血压和贫血的儿童更多。在早期诊断为 CKD 的儿童中,高血压发病年龄更早。